Monthly Archives: May 2015

Background/Intro: Studies have continually shown that community pharmacists can impact and improve patient outcomes if they utilize clinical skills during the dispensing process. The question that arises is: How can we change current reimbursement models to reward pharmacies for the clinical and cognitive services we provide in the dispensing role? Traditionally, as highlighted in previous......
Continue Reading →
To say that Medication Adherence is a hot topic in many pharmacies is an understatement. With the Proportion of Days Covered (PDC) being the focus of three of the five CMS performance measures for pharmacy, medication synchronization services are being adopted by many pharmacies. Synchronization is one strategy to improve patient compliance, making it less likely......
Continue Reading →
It will be interesting to watch as recent legislation in Washington State has given pharmacists provider status for commercial (non-medicare) health plans. This is a step in the right direction for pharmacy as reimbursement for drug product reaches record lows. Pharmacists need to step up to this challenge and utilize their clinical knowledge to advance......
Continue Reading →
Pharmacies are being paid less and less for prescription drugs, and adequate reimbursement for clinical services is still not a reality. At the same time, pharmacies are being evaluated on performance, and this requires investments in the practice. Keeping the bottom line balanced means that today’s pharmacy owner needs to maximize efficiency in their pharmacy......
Continue Reading →
Kevin Schweers with NCPA posted a piece about the PBM industry last month on “The Dose” (NCPA’s blog). It is an interesting read and ties in with some of the themes here on the Thriving Pharmacist’s Blog. You can read his post at That Man Behind the Curtain? Pay No Attention...
Continue Reading →
One of the more interesting aspects of writing a blog for public consumption is the great conversations that can take place as a result. One such conversation took place this evening when two delightful gentlemen called me to discuss some of my observations in The Rewards of Performance. These gentlemen represented the plan that I discussed......
Continue Reading →
The pharmacist, acting as an interventionist, needs to focus not only on the prescription(s) being filled at the present time, but also in the entire patient profile. This enables them to look for potential adverse drug reactions. At the counter, the pharmacist can determine if the patient is experiencing these potential events....
Continue Reading →
Yesterday, our pharmacies received an update from a major Part D plan in our area. This update stated: Effective immediately, [plan] will continue to cover brand name ABILIFY at the non-Preferred Brand Tier. The generic, aripiprazole, will NOT be covered for the [plan] members. Please continue to dispense ABILIFY  rather than substituting the generic product…......
Continue Reading →
For the first time, numbers from CMS hint at how much Pharmacy Benefit Managers may profit for their role of managing the Prescription Drug Plans. ...
Continue Reading →
An EXTRA dose of Thriving for your weekend reading, with a follow-up to yesterday's "Rewards for Performance" where we address flaws in claims based PDC and explaining Double Jeopardy with respect to performance payments....
Continue Reading →